Provided by Tiger Trade Technology Pte. Ltd.

Bioxytran, Inc.

0.0449
-0.0021-4.47%
Volume:500.58K
Turnover:20.89K
Market Cap:4.45M
PE:-1.88
High:0.0466
Open:0.0465
Low:0.0382
Close:0.0470
52wk High:0.2283
52wk Low:0.0342
Shares:99.10M
Float Shares:98.60M
Volume Ratio:4.48
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0239
EPS(LYR):-0.0379
ROE:--
ROA:-687.83%
PB:-1.51
PE(LYR):-1.18

Loading ...

Feb 17, 2026

Major Issues Report

Form 8-K - Current report
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 03, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 12, 2025

Correspondence

Form CORRESP - Correspondence
Feb 12, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 05, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 22, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

Major Issues Report

Form 8-K - Current report